DrugDashboards

6% Hetastarch In 0.9% Sodium Chloride

6% Hetastarch In 0.9% Sodium Chloride · HETASTARCH 6 g/100mL · Injection, Solution · Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1317-01 · 500 mL in 1 CONTAINER · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
BA740193
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of 6% Hetastarch In 0.9% Sodium Chloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
HF Acquisition Co LLC, DBA HealthFirstHETASTARCH 6 g/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "6% Hetastarch In 0.9% Sodium Chloride — NDC 51662-1317-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51662131701.

Free to cite with attribution — see how the data is put together.